Investors

Stock Quote

ICCC Stock Price

Current: $6.38

Data provided by Yahoo Finance. Prices may be delayed. Not financial advice.

Press Releases

Recent News | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014

SEC Filings

SEC Filings

Annual Report and Proxy

Corporate
Governance

ICCC Code of Conduct

Charter and Powers of the Audit Committee

Nominating Committee Charter

Management & Directors

2020 Press Releases

12-15-20 ImmuCell Announces Restructuring of its Bank Debt

11-12-20 ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020

11-05-20 ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020

10-06-20 ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020

08-12-20 ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020

08-06-20 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020

07-07-20 ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020

06-16-20 ImmuCell Receives $500,000 Loan from the Maine Technology Institute

05-14-20 ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference

05-14-20 ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

05-13-20 ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020

05-07-20 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020

04-14-20 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program

04-02-20 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020

3-11-20 ImmuCell Announces Refinancing of its Bank Debt

2-18-20 ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019

2-13-20 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019

1-21-20 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019

Company Contact

Olivier te Boekhorst

President & CEO

investor.relations@immucell.com

Investor Contact

Lytham Partners, LLC

iccc@lythampartners.com

602.889.9700